biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by rustycaton Sep 24, 2018 4:29pm

86 Views

Post# 28680652

RE:RE:RE:RE:Deals, deals and more deals

regardless,
Honestly, did you never research the success rate for preclinical biotech? Hint, it's probably less than one percent. Quit trying to bottom feed, and wait for positive news. Sure the share price will jump, but it will also fall back. At least you'll stop your insane chasing the price to the bottom. Your investing is painful to watch, but it can change.

Bullboard Posts

MDA Space stock blasts off on Q3 financial results